Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment

Ann Rheum Dis. 2012 Jul;71(7):1151-6. doi: 10.1136/annrheumdis-2011-200751. Epub 2012 Jan 20.

Abstract

Background: Inflammatory rheumatic diseases have been associated with increased cardiovascular risk and arterial stiffness. Polymyalgia rheumatica (PMR), a disease which affects primarily older people, is characterised by a systemic inflammatory response but little is known about aortic involvement in PMR. A study was undertaken to investigate whether aortic stiffness is increased in PMR and whether it improves after steroid treatment.

Methods: Thirty-nine patients with PMR (age 72 ± 8 years, 44% men, blood pressure (BP) 134/75 ± 16/9 mm Hg) and 39 age-, sex- and BP-matched control subjects underwent aortic pulse wave velocity (PWV) determination. Aortic augmentation as a measure of the impact of the reflection wave on central haemodynamics was also measured and corrected for heart rate. Twenty-nine of the patients were re-examined after 4 weeks of treatment with prednisone at a dose of 15 mg/day.

Results: Aortic PWV was higher in patients with PMR than in control subjects (12.4 ± 4 vs 10.2 ± 2 m/s, p<0.01). Treatment was followed by a reduction in heart rate (from 78 ± 12 to 70 ± 10 beats/min, p<0.001) and no significant change in BP. Aortic PWV decreased after prednisone treatment (from 11.8 ± 3 to 10.5 ± 3 m/s, p=0.015), and the difference was independent of BP and heart rate changes. The change in aortic PWV had a direct correlation with percentage change in plasma C reactive protein (r=0.40, p=0.037). Treatment was also associated with a significant reduction in aortic augmentation index (from 34 ± 7% to 29 ± 8%, p=0.012).

Conclusions: Polymyalgia rheumatica is associated with increased aortic stiffness which may improve upon reduction of systemic inflammation induced by treatment with glucocorticoids.

MeSH terms

  • Aged
  • Antirheumatic Agents / therapeutic use*
  • Arteriosclerosis / complications
  • Arteriosclerosis / drug therapy*
  • Arteriosclerosis / pathology
  • Blood Flow Velocity / drug effects
  • Blood Flow Velocity / physiology
  • Female
  • Glucocorticoids / therapeutic use*
  • Hemodynamics
  • Humans
  • Male
  • Polymyalgia Rheumatica / complications
  • Polymyalgia Rheumatica / drug therapy*
  • Polymyalgia Rheumatica / pathology
  • Pulsatile Flow / drug effects
  • Treatment Outcome
  • Vascular Stiffness / drug effects*
  • Vascular Stiffness / physiology

Substances

  • Antirheumatic Agents
  • Glucocorticoids